Matt Cartwright actually said...
Your decision to pursue this course of action in the Federal courts puts at risk not only critical consumer protections, such as those protecting individuals suffering from preexisting conditions, but also other important provisions of that law such as the Medicaid expansion, dependent coverage for young adults to age 26, coverage for preventative services, and the regulatory pathway for FDA approval of biosimilar drugs.
03/27/2019